|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 20/16/20 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 15/16/15 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 09/12/2014 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 25/08/2016 | |
| Director/Board Member | 58 | 25/08/2016 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | +1.31% | +54.27% | +117.14% | 1,13500Cr | |
| -1.42% | +3.23% | +38.56% | +74.05% | 64TCr | |
| +0.16% | +0.08% | +25.29% | +96.64% | 50TCr | |
| -0.31% | +3.09% | +44.14% | +64.55% | 38TCr | |
| -1.34% | -0.47% | +66.04% | +40.18% | 36TCr | |
| -0.68% | +2.65% | +22.98% | +49.15% | 29TCr | |
| -1.20% | +3.04% | +2.33% | +21.60% | 27TCr | |
| -1.79% | +1.57% | +50.56% | +61.40% | 24TCr | |
| -0.73% | -0.10% | +29.02% | +99.06% | 19TCr | |
| Average | -1.09% | +2.17% | +37.02% | +69.31% | 44.49TCr | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +80.33% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
